Activities
Advancing Treatment of Chronic Kidney Disease in Patients With Diabetes: Key Considerations for Pharmacists
0290-0000-21-284-H01-P
This activity will delve into emerging clinical data for MRAs and present interventions pharmacists can make to help improve outcomes of patients with type 2 diabetes and CKD.
2.00
Updates on Treatment Advances in Rheumatoid Arthritis: Considerations for Managed Care
0290-0000-21-290-H01-P
This activity will highlight data for investigational and recently approved agents for treatment of RA so managed care professionals can ensure optimization of care and access to new therapies for patients as they enter the newer treatment landscape for RA.
1.00
Managed Care Considerations for Management of Molluscum Contagiosum: Examining Emerging Treatments
0290-0000-21-281-H01-P
Examine the role of managed care professionals in the development of evidence-based clinical protocols for molluscum contagiosum
1.00
Evolving Evidence-Based Treatment Guidelines for Iron Deficiency Anemia in Inflammatory Bowel Disease: Considerations in Managed Care
0290-0000-21-265-H01-P
This activity will review the role of IV iron replacement in IBD and IDA and focus on the economic burden of these disease states and the impact of IV iron on healthcare resource use.
2.00